Fetal And Neonatal Alloimmune Thrombocytopenia
Last Posted: Apr 22, 2020
- Preimplantation genetic testing for a monogenic disorder can prevent live births affected by fetal and neonatal alloimmune thrombocytopenia.
Shaw Jacquelyn et al. Pediatric blood & cancer 2020 Apr e28239
- Maternal incompatibilities with fetal human platelet alloantigens -1a, -1b and -15 are the main causes of neonatal alloimmune thrombocytopenia in Russia.
Khaspekova S G, et al. Terapevticheskii arkhiv 2018 8 (7) 65-69
- Noninvasive prenatal diagnosis by cell-free DNA screening for fetomaternal HPA-1a platelet incompatibility.
Ferro Marta et al. Transfusion 2018 Sep
- HLA-DRB3*01:01 is a predictor of immunization against human platelet antigen-1a but not of the severity of fetal and neonatal alloimmune thrombocytopenia.
Wienzek-Lischka Sandra, et al. Transfusion 2016 12
- Non-invasive Prenatal Diagnosis of Feto-Maternal Platelet Incompatibility by Cold High Resolution Melting Analysis.
Ferro Marta, et al. Advances in experimental medicine and biology 2016 0 67-70
- Maternal HLA genotyping is not useful for predicting severity of fetal and neonatal alloimmune thrombocytopenia.
Sainio Susanna, et al. British journal of haematology 2016 10
- Genotyping of Human Platelet Antigens by BeadChip Microarray Technology.
Bertrand Gerald, et al. Methods in molecular biology (Clifton, N.J.) 2015 0 149-65
- Noninvasive fetal genotyping of human platelet antigen-1a using targeted massively parallel sequencing.
Wienzek-Lischka Sandra, et al. Transfusion 2015 6 (6 Pt 2) 1538-44
- Human platelet antigen alleles in 998 Taiwanese blood donors determined by sequence-specific primer polymerase chain reaction.
Pai Shun-Chung, et al. BioMed research international 2013 0 973789
- Compound heterozygosity of HLA-DRB3*01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia.
Loewenthal Ron, et al. Transfusion 2013 2 (2) 344-52
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.